OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study
Leonard B. Bacharier, Jorge Máspero, Constance H. Katelaris, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 1, pp. 45-54
Closed Access | Times Cited: 28
Leonard B. Bacharier, Jorge Máspero, Constance H. Katelaris, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 1, pp. 45-54
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Mechanistic modelling of allergen-induced airways disease in early life
Hannah J. Pybus, Prakrati Dangarh, M. H. Ng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Hannah J. Pybus, Prakrati Dangarh, M. H. Ng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Update in paediatric asthma
Andrew Bush
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
Andrew Bush
Current Opinion in Pulmonary Medicine (2025)
Closed Access | Times Cited: 1
The new biologic drugs: Which children with asthma should get what?
Kushalinii Hillson, Sejal Saglani, Andrew Bush
Pediatric Pulmonology (2024)
Open Access | Times Cited: 6
Kushalinii Hillson, Sejal Saglani, Andrew Bush
Pediatric Pulmonology (2024)
Open Access | Times Cited: 6
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Update in paediatric asthma 2024
Andrew Bush
Pediatric Respirology and Critical Care Medicine (2024) Vol. 8, Iss. 1, pp. 3-10
Closed Access | Times Cited: 4
Andrew Bush
Pediatric Respirology and Critical Care Medicine (2024) Vol. 8, Iss. 1, pp. 3-10
Closed Access | Times Cited: 4
Type 2 Inflammation and Asthma in Children: A Narrative Review
Nikolaos G. Papadopoulos, Leonard B Bacharier, Daniel J Jackson, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2310-2324
Open Access | Times Cited: 4
Nikolaos G. Papadopoulos, Leonard B Bacharier, Daniel J Jackson, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2310-2324
Open Access | Times Cited: 4
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)
Jorge Máspero, Martti Antila, A. Deschildre, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3303-3312
Open Access | Times Cited: 4
Jorge Máspero, Martti Antila, A. Deschildre, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 12, pp. 3303-3312
Open Access | Times Cited: 4
Modern Possibilities of Usage Dupilumab in Children
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
Yanhua Chen, Ni Jiang, Ming Li, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access
Yanhua Chen, Ni Jiang, Ming Li, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group
Cristiana Indolfi, Angela Klain, Marina Capuano, et al.
Children (2025) Vol. 12, Iss. 2, pp. 167-167
Open Access
Cristiana Indolfi, Angela Klain, Marina Capuano, et al.
Children (2025) Vol. 12, Iss. 2, pp. 167-167
Open Access
Detection of Breath Nitric Oxide at Ppb Level Based on Multiperiodic Spectral Reconstruction Neural Network
Rui Zhu, Jie Gao, Qi Tian, et al.
Analytical Chemistry (2025)
Closed Access
Rui Zhu, Jie Gao, Qi Tian, et al.
Analytical Chemistry (2025)
Closed Access
Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region
Qingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Clinical & Experimental Allergy (2025)
Open Access
Qingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Clinical & Experimental Allergy (2025)
Open Access
WHAT WE KNOW TO DATE ABOUT EARLY TREATMENT WITH BIOLOGICS IN SEVERE ASTHMA
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Luis Pérez de Llano, Mary Ann Bonilla, Elisa Luzón, et al.
Open Respiratory Archives (2025) Vol. 7, Iss. 2, pp. 100418-100418
Open Access
Management of severe asthma in children: current insights and future directions
Maria De Filippo, Riccardo Castagnoli, Ilaria Brambilla, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Maria De Filippo, Riccardo Castagnoli, Ilaria Brambilla, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Biological treatments in childhood asthma
Antonio Nieto, María Nieto, Ángel Mazón
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 3, pp. 114-121
Closed Access | Times Cited: 2
Antonio Nieto, María Nieto, Ángel Mazón
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 3, pp. 114-121
Closed Access | Times Cited: 2
Evaluating Severe Therapy-Resistant Asthma in Children: Diagnostic and Therapeutic Strategies
Andrew Bush
Medicina (2024) Vol. 60, Iss. 11, pp. 1799-1799
Open Access | Times Cited: 2
Andrew Bush
Medicina (2024) Vol. 60, Iss. 11, pp. 1799-1799
Open Access | Times Cited: 2
The Evolution of Scientific Knowledge in Childhood Asthma over Time: A Surprising History
Laura Venditto, Sonia Morano, Giuliana Ferrante, et al.
Children (2024) Vol. 11, Iss. 2, pp. 262-262
Open Access | Times Cited: 2
Laura Venditto, Sonia Morano, Giuliana Ferrante, et al.
Children (2024) Vol. 11, Iss. 2, pp. 262-262
Open Access | Times Cited: 2
An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
Dupilumab 200 mg was efficacious in children (6–11 years) with moderate‐to‐severe asthma for up to 2 years: EXCURSION open‐label extension study
Wanda Phipatanakul, Christian Vogelberg, Leonard B. Bacharier, et al.
Pediatric Pulmonology (2024) Vol. 59, Iss. 11, pp. 2976-2983
Open Access | Times Cited: 2
Wanda Phipatanakul, Christian Vogelberg, Leonard B. Bacharier, et al.
Pediatric Pulmonology (2024) Vol. 59, Iss. 11, pp. 2976-2983
Open Access | Times Cited: 2
Dupilumab: VOYAGE of discovery leading to a further EXCURSION
Emmanouil Paraskakis, Andrew Bush
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 1, pp. 5-7
Closed Access | Times Cited: 3
Emmanouil Paraskakis, Andrew Bush
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 1, pp. 5-7
Closed Access | Times Cited: 3
ERS International Congress 2022: highlights from the Airway Diseases Assembly
Augusta Beech, Andrea Portacci, Beatrice Herrero-Cortina, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00034-2023
Open Access | Times Cited: 2
Augusta Beech, Andrea Portacci, Beatrice Herrero-Cortina, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00034-2023
Open Access | Times Cited: 2
Pediatric Pulmonology 2023 Year in Review: Asthma
Andre Espaillat, Nicole Stephenson, Ceila E. Loughlin
Authorea (Authorea) (2024)
Open Access
Andre Espaillat, Nicole Stephenson, Ceila E. Loughlin
Authorea (Authorea) (2024)
Open Access
Biologikatherapie in der Behandlung der atopischen Dermatitis und des Asthma bronchiale
Nora Knappe, Christian Vogelberg
Kinder- und Jugendmedizin (2024) Vol. 24, Iss. 03, pp. 177-184
Closed Access
Nora Knappe, Christian Vogelberg
Kinder- und Jugendmedizin (2024) Vol. 24, Iss. 03, pp. 177-184
Closed Access
De l’asthme difficile à traiter à l’asthme sévère : palier 5
Stéphanie Lejeune, E. Hullo, P Bierme, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, pp. e55-e74
Closed Access
Stéphanie Lejeune, E. Hullo, P Bierme, et al.
Revue des Maladies Respiratoires (2024) Vol. 41, pp. e55-e74
Closed Access
